{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses conformational changes and membrane affinity related to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined through conformational changes and membrane interactions."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "smFRET is used to assess protein conformational changes and membrane interactions.",
          "judgment": "Yes",
          "reasoning": "smFRET is a valid and applicable technique for studying protein conformational changes.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The text does not mention specific controls or replicates, but smFRET is a widely accepted technique.",
          "judgment": "Yes",
          "reasoning": "smFRET is a validated technique, supporting the assay's validity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant shows reduced FRET efficiency, indicating conformational changes and reduced membrane affinity, supported by a valid assay. This evidence supports pathogenicity with a strength rating of PS3_supporting."
    }
  ]
}